SESSION TITLE: Wednesday Abstract Posters SESSION TYPE: Original Investigation Posters PRESENTED ON: 10/23/2019 09:45 AM - 10:45 AM PURPOSE: Restless Legs Syndrome (RLS) is a clinical syndrome that affects approximately 10% of the general population. It is more prevalent in patients with advanced age, renal failure, pregnancy, diabetes mellitus, medications, myopathy, neuropathy, rheumatoid arthritis, and iron deficiency anemia. Increased awareness of RLS in patients with these disorders has led to more timely treatment. However, the prevalence of RLS in patients with Cystic Fibrosis (CF) has not been fully investigated. The objective of the study was to determine the prevalence of RLS symptoms in patients with CF. We also evaluate the impact of this disorder on quality of life via RLS Quality of Life (QoL) survey and severity of symptoms via an International RLS Study Group (IRLS) Rating Scale. METHODS: This research project was done via prospective survey and chart review. Previously validated RLS survey tools were used to measure the presence of RLS. A one-page survey featuring the core symptoms of RLS was administered to 77 subjects with CF in an academic adult CF program. RLS herald symptoms as agreed upon by the IRLS were incorporated as 4 key questions addressing RLS. This survey was considered positive for RLS if 4 of 4 core symptoms were present and those patients were subsequently administered the IRLS Rating Scale and RLS QoL questionnaire. RESULTS: Results of our study show RLS symptoms prevalence of 27% in subjects with CF. Average calculated score on IRLS Rating Scale was 16, suggesting moderate severity. RLS QoL questionnaire, reveals that RLS affects concentration , social activity, sexual health and work productivity in this population. CONCLUSIONS: The association of RLS symptoms and CF has not been well defined. Our study suggests that RLS symptoms are prevalent in CF and affects their quality of life. The pathophysiology of this relationship has not been fully described, however it may involve iron deficiency anemia from chronic inflammation, hemoptysis, gastrointestinal blood loss or iron malabsorption. Additionally, colonization with Pseudomonas Aeruginosa can result in iron deficiency as it competes with its host for iron in creating its own biofilm. Furthermore, medication toxicity, renal failure and diabetes mellitus in this patient population can also be contributing factors. Further investigations are being done to better understand this association. CLINICAL IMPLICATIONS: CF patients, over time, may suffer from significant fatigue mainly because of their advancing lung disease. However, heightened awareness of other contributing factors such as RLS can aid in timely treatment and improving their overall quality of life. DISCLOSURES: No relevant relationships by Rose Franco, source=Web Response No relevant relationships by Jeanette Graf, source=Web Response No relevant relationships by Erin Hubertz, source=Web Response No relevant relationships by Dmitriy Kogan, source=Web Response No relevant relationships by Jatan Shah, source=Web Response
Read full abstract